Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
DMT-310 by Dermata Therapeutics for Acne Vulgaris: Likelihood of Approval
DMT-310 is under clinical development by Dermata Therapeutics and currently in Phase III for Acne Vulgaris. According to GlobalData, Phase...
Data Insights
DMT-310 by Dermata Therapeutics for Psoriasis: Likelihood of Approval
DMT-310 is under clinical development by Dermata Therapeutics and currently in Phase I for Psoriasis. According to GlobalData, Phase I...